Novo Nordisk A/S ADR | Income Statement
Fiscal year is January-December. All values DKK Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
83,572
88,806
107,927
111,780
111,696
111,831
Cost of Goods Sold (COGS) incl. D&A
14,714
15,112
16,672
17,696
18,218
18,906
Gross Income
68,858
73,694
91,255
94,084
93,478
92,925
SG&A Expense
38,018
39,459
44,987
45,860
45,251
46,725
EBIT
30,840
34,235
46,268
48,224
48,238
46,200
Unusual Expense
665
1,811
5,734
783
293
1,592
Non Operating Income/Expense
1,018
1,721
3,027
431
224
3,101
Interest Expense
55
150
148
150
158
157
Pretax Income
32,539
34,096
43,469
47,774
48,666
47,603
Income Tax
7,355
7,615
8,623
9,873
10,550
8,987
Equity in Affiliates
-
-
14
24
14
12
Consolidated Net Income
25,184
26,481
34,860
37,925
38,130
38,628
Net Income
25,184
26,481
34,860
37,925
38,130
38,628
Net Income After Extraordinaries
25,184
26,481
34,860
37,925
38,130
38,628
Net Income Available to Common
25,184
26,481
34,860
37,925
38,130
38,628
EPS (Basic)
9.40
10.10
13.56
14.99
15.42
15.96
Basic Shares Outstanding
2,679
2,621
2,571
2,530
2,473
2,420
EPS (Diluted)
9.35
10.07
13.52
14.96
15.39
15.93
Diluted Shares Outstanding
2,694
2,630
2,578
2,535
2,478
2,424
EBITDA
33,495
37,031
48,887
50,875
51,108
50,009
Other Operating Expense
-
-
-
-
11
-
Non-Operating Interest Income
71
101
56
52
69
51
About Novo Nordisk A/S
View Profile
